Zydus Lifesciences Ltd reported its Q3 FY25 financial results, showing a revenue of Rs. 52,691 million (up 17% YoY) and a net profit of Rs. 10,235 million (up 30% YoY). For the nine months ending December 31, 2024, revenues were Rs. 167,136 million (up 19% YoY) with a net profit of Rs. 33,546 million (up 25% YoY).